Trends in the Clinical Presentation of Uveal Melanoma During the COVID-19 Pandemic.
Ophthalmic Surg Lasers Imaging Retina
; 55(5): 278-284, 2024 May.
Article
em En
| MEDLINE
| ID: mdl-38408223
ABSTRACT
BACKGROUND AND OBJECTIVE:
The objective was to evaluate factors associated with clinical presentation of uveal melanoma (UM) during the initial two years of the coronavirus disease 2019 pandemic. PATIENTS ANDMETHODS:
This was a multi-site, retrospective cohort study of patients treated for uveal melanoma during the first (early) and second (late) year of the pandemic compared with the year prior (control).RESULTS:
A total of 48, 67, and 75 patients were in the control, early, and late cohorts, respectively. The early cohort had a higher frequency of large tumors (control 29.2%, early 40.3%, late 29.3%; P < 0.001) at presentation. Both the early and late cohorts had higher rates of enucleation (control 8.33%, early 20.9%, late 18.67%; P ≤ 0.0338) compared to the control cohort.CONCLUSIONS:
While there was an increase in large tumors along with a rise in enucleation during the first year of the pandemic, enucleation rates remained elevated even while tumor sizes normalized. [Ophthalmic Surg Lasers Imaging Retina 2024;55278-284.].
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Uveais
/
Enucleação Ocular
/
SARS-CoV-2
/
COVID-19
/
Melanoma
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ophthalmic Surg Lasers Imaging Retina
Ano de publicação:
2024
Tipo de documento:
Article